GGrantIndex
← Leaderboards

Dejana K Braithwaite

University Of Florida

$4,149,456
Attributed
$7,515,933
Total exposure
5
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.3M · FY200925
$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$7,515,933 · 5

By mechanism

R01$7,175,811 · 3
P30$215,536 · 1
R03$124,586 · 1

Top collaborators

Most similar at University Of Florida

Same institution · by research overlap

Others in their field

Top investigators on “Cancer Etiology

Research focus

Cancer EtiologyScreeningPublic HealthPoliciesCessation Of LifeMemberModels And SimulationComorbidityFundingFutureSocioeconomic StatusInnovationRaceElectronic Health RecordElderlyPublic Health RelevanceHigh RiskSimulationMalignant Neoplasm Of LungProviderDiagnosisLife ExpectancyAdultInfrastructure

Grant awards (20)

Personalized screening for lung cancer: the importance of co-existing chronic conditions to clinical practice and policy$637,797
R01 · FY2025 · CA · contact PI
Advancing Precision Lung Cancer Surveillance and Outcomes in Diverse Populations (PLuS2)$543,139
R01 · FY2025 · CA · contact PI
Cancer Control and Population Sciences Research Program$73,104
P30 · FY2025 · CA · contact PI
Personalized screening for lung cancer: the importance of co-existing chronic conditions to clinical practice and policy$608,786
R01 · FY2024 · CA · contact PI
Advancing Precision Lung Cancer Surveillance and Outcomes in Diverse Populations (PLuS2)$497,819
R01 · FY2024 · CA · contact PI
Cancer Control and Population Sciences Research Program$71,216
P30 · FY2024 · CA · contact PI
Personalized screening for lung cancer: the importance of co-existing chronic conditions to clinical practice and policy$65,002
R01 · FY2024 · CA · contact PI
Advancing Precision Lung Cancer Surveillance and Outcomes in Diverse Populations (PLuS2)$556,496
R01 · FY2023 · CA · contact PI
Cancer Control and Population Sciences Research Program$71,216
P30 · FY2023 · CA · contact PI
Diversity Supplement: Personalized screening for lung cancer: the importance of co-existing chronic conditions to clinical practice and policy$55,355
R01 · FY2023 · CA · contact PI
Personalized screening for lung cancer: the importance of co-existing chronic conditions to clinical practice and policy$626,652
R01 · FY2022 · CA · contact PI
Personalized screening for lung cancer: the importance of co-existing chronic conditions to clinical practice and policy$637,512
R01 · FY2021 · CA · contact PI
Personalized screening for lung cancer: the importance of co-existing chronic conditions to clinical practice and policy$689,368
R01 · FY2020 · CA · contact PI
COMORBIDITY AND SCREENING OUTCOMES AMONG OLDER WOMEN UNDERGOING MAMMOGRAPHY$311,086
R01 · FY2020 · CA · contact PI
COMORBIDITY AND SCREENING OUTCOMES AMONG OLDER WOMEN UNDERGOING MAMMOGRAPHY$25,591
R01 · FY2020 · CA · contact PI
COMORBIDITY AND SCREENING OUTCOMES AMONG OLDER WOMEN UNDERGOING MAMMOGRAPHY$504,989
R01 · FY2019 · CA · contact PI
COMORBIDITY AND SCREENING OUTCOMES AMONG OLDER WOMEN UNDERGOING MAMMOGRAPHY$700,730
R01 · FY2018 · CA · contact PI
Comorbidity and screening outcomes among older women undergoing mammography$715,489
R01 · FY2017 · CA · contact PI
Etiology of breast development in the BCERC network: role of socioeconomic status$62,310
R03 · FY2010 · CA · contact PI
Etiology of breast development in the BCERC network: role of socioeconomic status$62,276
R03 · FY2009 · CA · contact PI